Outcomes After Tricuspid Valve Operations in Patients With Drug-Use Infective Endocarditis
- 22 October 2022
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 185, 80-86
- https://doi.org/10.1016/j.amjcard.2022.08.033
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Tricuspid Regurgitation in Patients With Pacemakers and Implantable Cardiac Defibrillators: A Comprehensive ReviewClinical Cardiology, 2013
- Isolated Tricuspid Valve Surgery: Predictors of Adverse Outcome and SurvivalHeart, Lung and Circulation, 2013
- Novel percutaneous transcatheter intervention for refractory active endocarditis as a bridge to surgery–angiovac aspiration systemCatheterization and Cardiovascular Interventions, 2013
- Surgical Treatment for Isolated Tricuspid Valve EndocarditisCirculation Journal, 2013
- Right-sided infective endocarditis: surgical managementEuropean Journal of Cardio-Thoracic Surgery, 2012
- Long-Term Outcome for the Surgical Treatment of Infective Endocarditis With a Focus on Intravenous Drug UsersThe Annals of Thoracic Surgery, 2012
- Preoperative Factors Associated With Adverse Outcome After Tricuspid Valve ReplacementJournal of the American College of Cardiology, 2011
- Midterm Follow-Up of Tricuspid Valve Reconstruction Due to Active Infective EndocarditisThe Annals of Thoracic Surgery, 2007
- Surgical treatment of right-sided active infective endocarditis with or without involvement of the left heart: 20-year single center experience☆European Journal of Cardio-Thoracic Surgery, 2007
- Analysis of mortality and risk factors associated with native valve endocarditis in drug users: The importance of vegetation sizeAmerican Heart Journal, 2005